Sanofi Makes Pledge
Along with other leading biopharmaceutical companies, Sanofi has made a pledge to uphold the integrity of the scientific process as we work towards potential regulatory filings and approvals of the first COVID-19 vaccines.
Our Response to COVID-19
Adapting to Stay Ahead of Preventable Infectious Threats
Our society always adapts, and this includes new ways to protect ourselves from the spread of disease. Elaine O’Hara, Chief Commercial Officer NA at Sanofi Pasteur, reflects on the importance of vaccines and shares the new resources Sanofi has developed for health care professionals.